Raffles Medical Group Ltd (SGX:BSL)

Raffles Medical Group Balance Sheet

Financials in millions SGD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	262.3	310.79	343.67	343.6	253.13	264.99
Cash & Short-Term Investments	262.3	310.79	343.67	343.6	253.13	264.99
Cash Growth	-15.60%	-9.57%	0.02%	35.74%	-4.48%	30.46%
Receivables	122.46	113.75	120.59	128.63	228.12	160.74
Inventory	10.68	11.26	10.76	12.47	13.1	13.37
Total Current Assets	395.44	435.81	475.03	484.7	494.35	439.1
Property, Plant & Equipment	735.16	741.4	748.25	768.3	739.07	797.36
Goodwill	8.03	7.75	8.21	10.76	11.15	18.32
Other Intangible Assets	5.51	6.17	7.27	8.08	9.12	13.51
Long-Term Accounts Receivable	3	3.02	2.55	7.74	2.27	1.86
Long-Term Deferred Tax Assets	1.98	2.2	2.09	2.55	2.43	1.14
Other Long-Term Assets	233.6	233.6	246.1	246.1	273.4	274
Total Assets	1,383	1,430	1,490	1,528	1,532	1,545

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	168.04	184.63	218.48	208.96	206.86	251.39
Short-Term Debt	-	-	-	1.72	1.9	2.18
Current Portion of Long-Term Debt	-	49.7	6.87	16.02	9.67	96.3
Current Portion of Leases	11.82	10.29	9.53	10.05	9.66	10.24
Current Income Taxes Payable	21.15	24.35	24.78	27.14	49.63	29.1
Current Unearned Revenue	-	-	-	112.8	82.53	-
Other Current Liabilities	104.28	64.62	80.99	2.7	2.74	27.41
Total Current Liabilities	305.29	333.58	340.64	379.38	362.99	416.61
Long-Term Debt	-	-	49.12	69.2	94.51	111.89
Long-Term Leases	22.36	27.43	22.66	27.71	13.44	13.68
Long-Term Deferred Tax Liabilities	8.07	7.86	7.9	8.08	7.76	10.15
Other Long-Term Liabilities	6.63	5.11	4.21	-	25.34	16.35
Total Liabilities	342.35	373.98	424.52	484.38	504.04	568.67

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	440.1	440.1	440.1	439.82	432.38	426.35
Retained Earnings	608.07	634.26	609.96	592.29	572.83	483.98
Treasury Stock	-48.09	-48.12	-30.58	-31.48	-26.89	-3.23
Comprehensive Income & Other	42.5	32.25	30.29	27.11	34.09	53.7
Total Common Equity	1,043	1,058	1,050	1,028	1,012	960.79
Minority Interest	-2.22	-2.52	15.21	16.11	15.35	15.83
Shareholders' Equity	1,040	1,056	1,065	1,044	1,028	976.62
Total Liabilities & Equity	1,383	1,430	1,490	1,528	1,532	1,545

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	34.18	87.42	88.17	124.7	129.18	234.28
Net Cash (Debt)	228.12	223.37	255.5	218.9	123.95	30.71
Net Cash Growth	2.13%	-12.58%	16.72%	76.61%	303.65%	-
Net Cash Per Share	0.12	0.12	0.14	0.12	0.07	0.02
Filing Date Shares Outstanding	1,840	1,840	1,853	1,857	1,859	1,862
Total Common Shares Outstanding	1,840	1,840	1,858	1,857	1,855	1,868
Working Capital	90.15	102.22	134.38	105.31	131.36	22.49
Book Value Per Share	0.57	0.58	0.56	0.55	0.55	0.51
Tangible Book Value	1,029	1,045	1,034	1,009	992.13	928.96
Tangible Book Value Per Share	0.56	0.57	0.56	0.54	0.53	0.50
Land	-	317.7	309.17	309.1	292.68	297.05
Machinery	-	105.54	109.35	104.36	96.67	113.29
Construction In Progress	-	1.51	1.17	5.46	2.07	0.14

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 2, 2026

Data Sources Report a data error